These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 15290699)

  • 1. A comparison of side effects of selective serotonin reuptake inhibitors and tricyclic antidepressants in older depressed patients: a meta-analysis.
    Wilson K; Mottram P
    Int J Geriatr Psychiatry; 2004 Aug; 19(8):754-62. PubMed ID: 15290699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antidepressants for depressed elderly.
    Mottram P; Wilson K; Strobl J
    Cochrane Database Syst Rev; 2006 Jan; 2006(1):CD003491. PubMed ID: 16437456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability.
    Anderson IM
    J Affect Disord; 2000 Apr; 58(1):19-36. PubMed ID: 10760555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SSRIS versus tricyclic antidepressants in depressed inpatients: a meta-analysis of efficacy and tolerability.
    Anderson IM
    Depress Anxiety; 1998; 7 Suppl 1():11-7. PubMed ID: 9597346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. WITHDRAWN: Treatment discontinuation with selective serotonin reuptake inhibitors (SSRIs) versus tricyclic antidepressants (TCAs).
    Barbui C; Hotopf M; Freemantle N; Boynton J; Churchill R; Eccles MP; Geddes JR; Hardy R; Lewis G; Mason JM
    Cochrane Database Syst Rev; 2007 Jul; (3):CD002791. PubMed ID: 17636706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective serotonin reuptake inhibitors versus tricyclic antidepressants in young patients: a meta-analysis of efficacy and acceptability.
    Qin B; Zhang Y; Zhou X; Cheng P; Liu Y; Chen J; Fu Y; Luo Q; Xie P
    Clin Ther; 2014 Jul; 36(7):1087-1095.e4. PubMed ID: 24998011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum levels and cardiovascular effects of tricyclic antidepressants and selective serotonin reuptake inhibitors in depressed patients.
    Rodriguez de la Torre B; Dreher J; Malevany I; Bagli M; Kolbinger M; Omran H; Lüderitz B; Rao ML
    Ther Drug Monit; 2001 Aug; 23(4):435-40. PubMed ID: 11477329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and tolerability of moclobemide in comparison with placebo, tricyclic antidepressants, and selective serotonin reuptake inhibitors in elderly depressed patients: a clinical overview.
    Amrein R; Stabl M; Henauer S; Affolter E; Jonkanski I
    Can J Psychiatry; 1997 Dec; 42(10):1043-50. PubMed ID: 9469236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacotherapy for major depression with melancholic features: relative efficacy of tricyclic versus selective serotonin reuptake inhibitor antidepressants.
    Perry PJ
    J Affect Disord; 1996 Jun; 39(1):1-6. PubMed ID: 8835647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological interventions for the treatment of depression in chronic obstructive pulmonary disease.
    Pollok J; van Agteren JE; Carson-Chahhoud KV
    Cochrane Database Syst Rev; 2018 Dec; 12(12):CD012346. PubMed ID: 30566235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Side-effect profile of fluoxetine in comparison with other SSRIs, tricyclic and newer antidepressants: a meta-analysis of clinical trial data.
    Brambilla P; Cipriani A; Hotopf M; Barbui C
    Pharmacopsychiatry; 2005 Mar; 38(2):69-77. PubMed ID: 15744630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meta-analytical studies on new antidepressants.
    Anderson IM
    Br Med Bull; 2001; 57():161-78. PubMed ID: 11719915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and tolerability of tricyclic antidepressants and SSRIs compared with placebo for treatment of depression in primary care: a meta-analysis.
    Arroll B; Macgillivray S; Ogston S; Reid I; Sullivan F; Williams B; Crombie I
    Ann Fam Med; 2005; 3(5):449-56. PubMed ID: 16189062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and tolerability considerations: tricyclic antidepressants vs. selective serotonin reuptake inhibitors.
    Peretti S; Judge R; Hindmarch I
    Acta Psychiatr Scand Suppl; 2000; 403():17-25. PubMed ID: 11019931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tricyclic antidepressants for preventing migraine in adults.
    Xu XM; Liu Y; Dong MX; Zou DZ; Wei YD
    Medicine (Baltimore); 2017 Jun; 96(22):e6989. PubMed ID: 28562550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of compliance between serotonin reuptake inhibitors and tricyclic antidepressants: a meta-analysis.
    Montgomery SA; Kasper S
    Int Clin Psychopharmacol; 1995 Jan; 9 Suppl 4():33-40. PubMed ID: 7622822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continuing treatment of depression in the elderly: a systematic review and meta-analysis of double-blinded randomized controlled trials with antidepressants.
    Kok RM; Heeren TJ; Nolen WA
    Am J Geriatr Psychiatry; 2011 Mar; 19(3):249-55. PubMed ID: 21425505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective serotonin reuptake inhibitors versus tricyclic and heterocyclic antidepressants: comparison of drug adherence.
    Barbui C; Hotopf M; Freemantle N; Boynton J; Churchill R; Eccles MP; Geddes JR; Hardy R; Lewis G; Mason JM
    Cochrane Database Syst Rev; 2000; (4):CD002791. PubMed ID: 11034764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are SSRIs better than TCAs? Comparison of SSRIs and TCAs: a meta-analysis.
    Steffens DC; Krishnan KR; Helms MJ
    Depress Anxiety; 1997; 6(1):10-8. PubMed ID: 9394870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective serotonin reuptake inhibitors: meta-analysis of discontinuation rates.
    Montgomery SA; Henry J; McDonald G; Dinan T; Lader M; Hindmarch I; Clare A; Nutt D
    Int Clin Psychopharmacol; 1994; 9(1):47-53. PubMed ID: 8195583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.